Carbogen Amcis, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, has completed the first inspection by the French regulatory authority, ANSM, at its sterile drug product manufacturing site in Saint-Beauzire, France. As a result, Carbogen Amcis has been granted a GMP certificate for the Saint-Beauzire facility, marking a significant milestone in the site’s successful start-up. “This achievement reflects our team’s dedication ...